Skip to main content
. 2020 Oct 23;3(10):e2021182. doi: 10.1001/jamanetworkopen.2020.21182

Table 1. Patient Characteristics.

Characteristic Patients in 2001-2006, No. (%) P valuea Patients in 2011-2015, No. (%) P valueb P for interaction
Overall (n = 6765) Western (n = 1173) Central (n = 1329) Eastern (n = 4263) Overall (n = 20 281) Western (n = 4403) Central (n = 5227) Eastern (n = 10 651)
Demographic
Age (range), y 66 (56-73) 65 (55-73) 65 (54-73) 67 (56-74) <.001 66 (56-73) 67 (56-75) 65 (56-75) 67 (57-76) <.001 <.001
Female sex 2010 (29.7) 322 (27.5) 361 (27.2) 1327 (31.1) .004 6328 (31.2) 1303 (29.6) 1543 (29.5) 3482 (32.7) <.001 <.001
CVD risk factor
Hypertension 3142 (46.4) 479 (40.8) 552 (41.5) 2111 (49.5) <.001 11 019 (54.3) 2218 (50.4) 2618 (50.1) 6183 (58.1) <.001 .59
Diabetes 1014 (15.0) 142 (12.1) 153 (11.5) 719 (16.9) <.001 4136 (20.4) 763 (17.3) 865 (16.6) 2508 (23.6) <.001 <.001
Dyslipidemia 249 (3.7) 42 (3.6) 28 (2.1) 179 (4.2) .002 1450 (7.1) 242 (5.5) 286 (5.5) 922 (8.7) <.001 <.001
Current smoker 2096 (31.0) 381 (32.5) 404 (30.4) 1311 (30.8) .46 6735 (33.2) 1437 (32.6) 1649 (31.6) 3649 (34.3) .002 <.001
Medical history
Ischemic stroke 621 (9.2) 67 (5.7) 108 (8.1) 446 (10.5) <.001 2364 (11.7) 428 (9.7) 527 (10.1) 1409 (13.2) <.001 <.001
Coronary heart disease 1500 (22.2) 212 (18.1) 253 (19.0) 1035 (24.3) <.001 5015 (24.7) 926 (21.0) 1288 (24.6) 2801 (26.3) <.001 .004
Myocardial infarction 665 (9.8) 90 (7.7) 107 (8.1) 468 (11.0) <.001 2034 (10.0) 389 (8.8) 453 (8.7) 1192 (11.2) <.001 .54
Clinical characteristic at presentation
No chest discomfort 559 (8.3) 92 (7.8) 120 (9.0) 347 (8.1) .50 1961 (9.7) 502 (11.4) 439 (8.4) 1020 (9.6) <.001 <.001
LBBB 128 (1.9) 29 (2.5) 33 (2.5) 66 (1.6) .03 254 (1.3) 64 (1.5) 58 (1.1) 132 (1.2) .31 <.001
Cardiac arrest 79 (1.2) 15 (1.3) 13 (1.0) 51 (1.2) .75 260 (1.3) 52 (1.2) 55 (1.1) 153 (1.4) .10 <.001
Cardiogenic shock 377 (5.6) 81 (6.9) 73 (5.5) 223 (5.2) .09 1296 (6.4) 284 (6.5) 334 (6.4) 678 (6.4) .98 <.001
Acute stroke 93 (1.4) 14 (1.2) 15 (1.1) 64 (1.5) .50 508 (2.5) 121 (2.8) 152 (2.9) 235 (2.2) .02 <.001
Kidney dysfunctionc,d 2228 (41.9) 440 (45.1) 366 (41.5) 1422 (41.2) .09 6159 (33.7) 1478 (36.5) 1604 (34.6) 3077 (32.1) <.001 <.001
HR >90 beats/min 1620 (23.9) 275 (23.4) 326 (24.5) 1019 (23.9) .81 4777 (23.6) 1052 (23.9) 1237 (23.7) 2488 (23.4) .76 <.001
SBP <100 mm Hg 912 (13.5) 163 (13.9) 202 (15.2) 547 (12.8) .08 1992 (9.8) 539 (12.2) 581 (11.1) 872 (8.2) <.001 <.001
White blood cell countd
6000-12 000/μL 3540 (64.3) 631 (63.5) 616 (61.1) 2293 (65.4) .04 11 868 (64.6) 2583 (63.7) 2960 (63.0) 6325 (65.8) .002 <.001
>12 000/μL 1384 (25.1) 262 (26.4) 263 (26.1) 859 (24.5) .35 4342 (23.6) 1023 (25.2) 1145 (24.4) 2174 (22.6) .002 <.001

Abbreviations: CVD indicates cardiovascular disease; HR, heart rate; LBBB, left bundle branch block; SBP, systolic blood pressure.

SI conversion factors: To convert white blood cell count to ×109/L, multiply by 0.001.

a

Test for difference among the Western, Central, and Eastern regions in 2001-2006.

b

Test for difference among the Western, Central, and Eastern regions in 2011-2015.

c

Kidney dysfunction was defined as serum creatinine >1.13 mg/dL (to convert to micromoles per liter, multiply by 88.4) or blood urea nitrogen >22.4 mg/dL (to convert to mmol/L, multiply by 0.357).

d

Percentages were calculated among patients with available measurements.